IL‐6 activates STAT3 to promote neutrophil infiltration and joint inflammation, while SOCS3, a negative regulator of STAT3, is upregulated during gout flares, potentially mitigating inflammation by suppressing STAT3 signaling [22, 29]. Here, IL6 is linked to gout.